Let’s Talk About Colds, Flus, and AHCC
It’s cold and flu season so it only makes sense that we get into Chapter 3 of The Patient’s Guide to AHCC, titled: Colds, Flus, and Other Infections. No one wants to deal with a cold, flu, or other serious infection. Especially since we’re often told to “wait it out” or “let it run its course” – good news is that there is a better way – to avoid the flus, colds, and infections all together.
This has resulted in the development of “superbugs” – bacteria that have become resistant to the antibiotics that were developed to destroy them. Because people are learning that not only are antibiotics less effective but also have challenging side effects, many folks are turning to natural treatments including vitamin C, echinacea, garlic, and ginseng. The problem with these natural treatments is that they have not been tightly studied.
The good news is that AHCC has been rigorously studied and the results of these studies have shown that AHCC offers a way to prevent and treat infections from the front line.
As you can read in detail in The Patient’s Guide to AHCC – AHCC is instrumental in building up, strengthening and supporting the immune system by activating specific cells such as NK cells and enhancing their activities.
Cold and Flu Facts
- One billion colds per year in the United States – this is a lot of missed days of work and school, not to mention the impact that it has on the healthcare system
- Children are hit the hardest, with six to ten colds a year
- Adults will generally get two to four colds a year
- The Centers for Disease Control and Prevention states that 20 percent of Americans get the flu each year
- 200,000 of these people will be hospitalized and an estimated 36,000 die per year from the flu
To learn more about the prevalence of colds, flus, and other infections such as MSRA, West Nile Virus, and pneumonia, read the full Chapter 3 of The Patient’s Guide to AHCC.
While we won’t dive into the deep details of the numerous studies done on the effectiveness of AHCC in preventing and treating the flu, we will highlight some interesting study results. To get all of the details on the studies, ead Chapter 3 of The Patient’s Guide to AHCC.
- Drexel University in Philadelphia conducted a study with two groups of mice: one infected with H1N1 flu virus and the other group was treated with AHCC prior to infection and throughout the infection. AHCC-treated mice had an increased survival rate, decreased symptoms, and experienced a shorter recovery period after being infected. AHCC-treated mice also had a reduced death rate from 25 to 5 percent. AHCC increased the activity of NK cells in the lungs and spleen and also facilitated the clearance of the virus from the treated mice.
- A Japanese study compared the effects of AHCC and the H5N1 flu vaccine together to the H5N1 flu vaccine alone. In the group of mice that only received the H5N1 vaccine, approximately 80 percent survived while in the group that received both AHCC and the H5N1 vaccine there was a 100 percent survival rate.
To read more details about these studies and more on the effectiveness of AHCC and the flu virus, read Chapter 3 of The Patient’s Guide to AHCC. This flu research clearly shows the impact that AHCC has in promoting the activity of NK cells. This speaks to the promise that AHCC has in being able to also treat the common cold.
Based on the success of the flu studies and other well-regarded studies, more research is ongoing to determine the role AHCC may play as a preventive during cold and flu season. We want you and your family stay healthy and well during this upcoming cold and flu season. Download he Patient’s Guide to AHCC to learn how you can give your family the protection it needs this fall and winter.